Joaquín Arribas Selected Research

Inflammation (Inflammations)

1/2018

PTBP1-Mediated Alternative Splicing Regulates the Inflammatory Secretome and the Pro-tumorigenic Effects of Senescent Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joaquín Arribas Research Topics

Disease

54	Neoplasms (Cancer) 01/2024 - 03/2003
33	Breast Neoplasms (Breast Cancer) 12/2023 - 03/2007
10	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2004
5	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2021 - 01/2018
4	Triple Negative Breast Neoplasms 03/2024 - 01/2019
3	Carcinogenesis 12/2018 - 03/2003
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Cachexia 12/2021
1	Muscular Atrophy (Muscle Atrophy) 12/2021
1	Disease Progression 01/2021
1	Encephalitis (Encephalitis, Rasmussen) 01/2021
1	Myocarditis (Carditis) 01/2021
1	Pathologic Complete Response 01/2019
1	Inflammation (Inflammations) 01/2018
1	Adenocarcinoma 04/2015
1	Fibrosis (Cirrhosis) 04/2015
1	Circulating Neoplastic Cells 11/2013

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2016
8	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2018 - 07/2006
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2004
6	Trastuzumab (Herceptin)FDA Link 12/2022 - 11/2014
6	Metalloproteases (Metalloproteinases)IBA 01/2010 - 05/2005
5	Phosphotransferases (Kinase)IBA 11/2021 - 08/2004
4	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 10/2004
4	human ERBB2 proteinIBA 03/2020 - 11/2010
3	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2022
3	Immunoconjugates (Immunoconjugate)IBA 12/2022 - 01/2017
3	Estrogen ReceptorsIBA 01/2022 - 11/2010
3	Messenger RNA (mRNA)IBA 01/2022 - 08/2004
3	CytokinesIBA 01/2021 - 05/2015
3	Imatinib Mesylate (Gleevec)FDA Link 02/2020 - 01/2018
3	AntibodiesIBA 12/2018 - 07/2006
3	ErbB Receptors (EGF Receptor)IBA 03/2007 - 10/2004
3	Peptide Hydrolases (Proteases)FDA Link 07/2005 - 12/2002
2	LigandsIBA 01/2024 - 01/2016
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023 - 01/2022
2	trastuzumab duocarmazineIBA 12/2022 - 03/2020
2	AntigensIBA 12/2022 - 10/2018
2	Lapatinib (GW572016)FDA Link 09/2022 - 11/2013
2	eribulin FDA Link 05/2022 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2019
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2021 - 06/2013
2	Bispecific AntibodiesIBA 01/2021 - 10/2018
2	Ado-Trastuzumab EmtansineIBA 03/2020 - 01/2017
2	Phenobarbital (Luminal)FDA Link 01/2018 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 10/2016 - 05/2015
2	Epidermal Growth Factor (EGF)IBA 01/2016 - 03/2003
2	Complementary DNA (cDNA)IBA 10/2004 - 08/2004
1	Histones (Histone)IBA 03/2024
1	ChromatinIBA 03/2024
1	HeterochromatinIBA 03/2024
1	ChemokinesIBA 01/2024
1	SuspensionsIBA 12/2023
1	Cancer VaccinesIBA 02/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2022
1	Chloroquine (Aralen)FDA LinkGeneric 09/2022
1	ribociclibIBA 01/2022
1	InterferonsIBA 01/2022
1	AlpelisibIBA 01/2022
1	PlatinumIBA 01/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	taxaneIBA 01/2021
1	Vitamin D FDA LinkGeneric 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	AnthracyclinesIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	capivasertibIBA 01/2020
1	Fulvestrant (Faslodex)FDA Link 01/2020
1	copanlisibIBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	Docetaxel (Taxotere)FDA Link 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Cyclin DIBA 01/2019
1	Ligases (Synthetase)IBA 01/2019
1	Taxoids (Taxanes)IBA 01/2019
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	ProteomeIBA 12/2018
1	Nuclear Proteins (Protein, Nuclear)IBA 12/2018
1	PM 01183IBA 11/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Caspase 8 (Caspase-8)IBA 11/2017
1	Blocking AntibodiesIBA 10/2016
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 10/2016
1	Drug CombinationsIBA 01/2016
1	Agammaglobulinaemia Tyrosine KinaseIBA 04/2015
1	ibrutinibIBA 04/2015

Therapy/Procedure

22	Therapeutics 02/2023 - 03/2003
5	Drug Therapy (Chemotherapy) 01/2024 - 11/2014
5	Immunotherapy 02/2023 - 01/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2023
1	Radiotherapy 01/2020
1	Aftercare (After-Treatment) 10/2019
1	Neoadjuvant Therapy 01/2019
1	Precision Medicine 01/2017